Factors that influence trust in non-standard stem cell therapies among patients with musculoskeletal conditions: a qualitative, constructivist grounded theory study
- 29 April 2026
- journal article
- Published by Taylor & Francis in Regenerative Medicine
- p. 1-12
Abstract
Stem cell interventions (SCIs) are an exciting area of regenerative medicine (RM) that may offer improved outcomes for many patients, including those suffering from musculoskeletal conditions. They can also raise regulatory tensions and policy challenges, including how to manage direct-to-consumer markets where nonstandard SCIs - those falling outside the standard of care and lacking sufficient evidence of safety or efficacy - are sold. Ongoing regulatory reform efforts in several countries, including Canada, to address these and other related issues would benefit from insights regarding what is important to patients for trust in SCIs and their providers. Through interviews involving eight participants with musculoskeletal conditions, this qualitative, constructivist grounded theory study presents a preliminary model of factors that influence some patients' trust in nonstandard SCIs. Participants' anticipated approaches to nonstandard SCIs were rooted in their lived experiences of pain and frustration, shaped through interactions with healthcare providers, and framed by assumptions about regulatory protection. Healthcare providers play a pivotal role in helping navigate and interpret information. These results highlight the importance of evidence-based approaches to governance that integrate patient voices, practitioner education, and regulatory accountability to protect patients and help advance responsible RM innovation.Keywords
Funding Information
- Canada’s Stem Cell Network (TST-CAR1-2)
This publication has 34 references indexed in Scilit:
- Stem cell injections for osteoarthritis of the kneeCochrane Database of Systematic Reviews, 2025
- Effective regulatory responses to predatory stem cell markets in Australia and CanadaCell Stem Cell, 2024
- Designing persuasive health education for patients seeking unproven stem cell interventionsStem Cell Reports, 2023
- Public Opinion and Expectations of Stem Cell Therapies in OrthopaedicsArthroscopy, 2021
- OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritisOsteoarthritis and Cartilage, 2019
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based InterventionsStem Cells Translational Medicine, 2018
- Workshop to address gaps in regulation of minimally manipulated autologous cell therapies for homologous use in CanadaCytotherapy, 2017
- Part 1: Defining unproven cellular therapiesCytotherapy, 2016
- Professional Regulation: A Potentially Valuable Tool in Responding to “Stem Cell Tourism”Stem Cell Reports, 2014
- Naturalistic inquiryInternational Journal of Intercultural Relations, 1985